Publication: Outcomes of phacoemulsification in patients with chronic ocular graft-versus-host disease
Open/View Files
Date
2015
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Springer Nature
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Saboo, Ujwala S., Francisco Amparo, Hasanain Shikari, Ula V. Jurkunas, and Reza Dana. 2015. “Outcomes of Phacoemulsification in Patients with Chronic Ocular Graft-Versus-Host Disease.” Graefe’s Archive for Clinical and Experimental Ophthalmology 253 (6) (January 27): 901–907. doi:10.1007/s00417-015-2940-3.
Research Data
Abstract
Purpose
To evaluate the outcomes of phacoemulsification in patients with ocular graft-versus-host disease (GVHD).
Methods
The occurrence of cataract, cataract surgery and its outcomes were analyzed in the medical records of 229 patients (458 eyes) with ocular GVHD. Outcome measures included pre- and postoperative corrected distance visual acuity (CDVA) and the rate of postoperative complications.
Results
From 458 eyes evaluated 58 were pseudophakic, from the 400 phakic eyes 238 (59%) presented with cataracts and 62 (26%) underwent cataract surgery. Analysis of postoperative complications and visual outcomes at one month was performed in 51 eyes in which detailed surgical and immediate postoperative records were available. Preoperatively, the mean CDVA was 0.67±0.57 LogMAR (Snellen 20/93) and improved postoperatively to 0.17±0.18 (Snellen 20/29) at one month (P<0.0001), and to 0.13±0.14 (Snellen 20/26) by the final follow-up visit (P<0.0001). Postoperative complications included: corneal epithelial defects (8%), filamentary keratitis (6%), worsening of corneal epitheliopathy (16%), posterior capsular opacification (18%), and cystoid macular edema (4%). A corrected distance visual acuity of 20/30 or better was achieved in 87% of the eyes; suboptimal CDVA improvement was accounted by severe ocular surface disease, pre-existing advanced glaucoma, and prior macular surgery.
Conclusions
Phacoemulsification in patients with chronic ocular GVHD is a safe and efficacious procedure resulting in significant visual improvement. Overall, postoperative adverse events responded well to timely management.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Open Access Policy Articles (OAP), as set forth at Terms of Service